DNA vaccines: Future strategies and relevance to intracellular pathogens

Immunology and Cell Biology

Volumn 79, Issue 6, 2001, Pages 537-546

  Sharma, A K ^a   Khuller, G K ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Cell mediated immune responses; HIV; T lymphocytes; Tuberculosis

Indexed keywords

DNA VACCINE; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 2; PLASMID DNA;

CELL POPULATION; CHEMOTHERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMORAL IMMUNITY; IMMUNITY; INFECTION CONTROL; NONHUMAN; PARAMETER; REVIEW; T LYMPHOCYTE; TUBERCULOSIS; VACCINATION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; FORECASTING; HUMANS; IMMUNITY, CELLULAR; PLASMIDS; TUBERCULOSIS; VACCINES, DNA;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 0035186635     PISSN: 08189641     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1711.2001.01044.x     Document Type: Review

References (98)

1. 37Ra
2. 37Rv and its protective efficacy against experimental tuberculosis
3. 37Rv
4. Induction of humoral and cellular immune responses by vaccination with Mycobacterium tuberculosis antigen 85 DNA
5. Generation of MHC-1 restricted cytotoxic T lymphocytes by expression of a vital protein in muscle cells: Antigen presentation by non-muscle cells
6. DNA based immunization induces continuous secretion of hepatitis B surface antigen and high levels of circulating antibody
7. First human trial of a DNA based vaccine for treatment of human immunodeficiency virus type 1 infection: Safety and host responses
8. Genetic immunization: A new era in vaccines and immunotherapy
9. DNA vaccine
10. A 'senseless' immune response to DNA
11. A plasmid encoding murine granulocyte macrophage colony stimulating factor increases protection conferred by a malaria DNA vaccine
12. Intranasal immunization of a DNA vaccine with interleukin-12 and granulocyte macrophage colony stimulating factor (GMCSF) expressing plasmids in liposomes induce strong mucosal and cell mediated immune responses against HIV-1 antigen
13. Manipulation of the immune responses to a plasmid-encoded viral antigen by coinoculation with plasmids expressing cytokines
14. Enhanced responses to a DNA vaccine encoding a fusion antigen that is directed to sites of immune induction
15. The dominant role of bone marrow derived cells in CTL induction following plasmid DNA immunization at different sites
16. Immunostimulatory DNA sequences necessary for effective intradermal gene vaccination
17. Generating and regulating immune responses through cutaneous gene delivery
18. Specific immune induction following DNA based immunization through in vivo transfection and activation of macrophages/antigen-presenting cells
19. Delivery of DNA vaccine by attenuated intracellular bacteria
20. Neonatal DNA immunization with an internal viral protein is effective in the presence of maternal antibodies and protects against subsequent viral challenge
21. Protiens expressed by DNA vaccines induce both local and systemic immune responses
22. DNA vaccines: A novel approach to immunization
23. Cellular mechanisms in inflammatory myopathies
24. The immunobiology of muscle
25. DNA immunization can stimulate florid local inflammation and the antiviral immunity induced varies depending on injection site
26. Immune mediated destruction of transfected muscle fibers after direct gene transfer with antigen expressing plasmid DNA
27. Simian immunodeficiency virus-specific cytotoxic T lymphocyte induction through DNA vaccination of rhesus monkeys
28. Genetic Vaccines
29. Involvement of an ATP-dependent peptide chaperone in cross-presentation after DNA immunization
30. DNA vaccination. Antigen presentation and the induction of immunity
31. Dendritic cell (DC) based anti infective strategies. DCs engineered to secrete IL-12 are a potent vaccine in a murine model of intracellular infection
32. T cell expression cloning of a Mycobacterium tuberculosis gene encoding a protective antigen associated with the early control of infection
33. Induction of antigen specific cytotoxic T lymphocyte in humans by a malaria DNA vaccine
34. Safety, tolerability and humoral immune responses after intramuscular administration of a malaria DNA vaccine to healthy adult volunteers
35. Cellular cytotoxic response induced by DNA vaccination in HIV-1 infected patients
36. Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus ankara
37. Induction of CD8+ T cells using heterologous prime boost immunization strategies
38. Enhanced T cell immunogenicity and protective efficacy of a HIV-1 vaccine regimen consisting of consecutive DNA priming and recombinant fowl pox virus boosting
39. Effective induction of HIV-specific CTL by multiepitope using gene gun in a combined vaccination regime
40. The combination of single and combination tuberculosis DNA vaccine
41. Co-immunization with DNA vaccines expressing granulocyte-macrophage colony-stimulating factor and mycobacterial secreted proteins enhances T cell immunity but not protective efficacy against Mycobacterium tuberculosis
42. Immunogenecity of DNA vaccines expressing tuberculosis proteins fused on tissue plasminogen activator signal sequence
43. DNA vaccination against tuberculosis: Expression of a ubiquitin-conjugated tuberculosis protein enhances antimycobacterial immunity
44. + T cell priming against the identified peptide after DNA vaccination of mice
45. Intranasal vaccination of mice against injection with M. tuberculosis
46. Vaccination against tuberculosis by DNA injection
47. Protection against tuberculosis by a plasmid DNA vaccine
48. Evaluation of new vaccines in the mouse and guinea pig model of tuberculosis
49. A single mycobacterial protein (hsp65) expressed by a transgenic antigen presenting cell vaccinates mice against tuberculosis
50. Therapy of tuberculosis in mice by DNA vaccination
51. Vaccinia expression of Mycobacterium tuberculosis secreted proteins: Tissue plasminogen activator signal sequence enhances expression and immunogenicity of M. tuberculosis Ag85
52. Quantifying residual HIV-1 replication in patients receiving combination antiretroviral therapy
53. Persistence of HIV-1 transcription in peripheral blood mononuclear cells in patients receiving potent antiretroviral therapy
54. Residual HIV-1 disease in the era of highly active antiretroviral therapy
55. Control of HIV despite the discontinuation of antiretroviral therapy
56. A striking property of recombinant pox viruses: Efficient inducers of in vivo expansion of primed CD8+ T cells
57. Mature dendritic cells infected with canarypox virus elicit strong antihuman immunodeficiency virus CD8+ and CD4+ T cell responses from chronically infected individuals
58. Neutralizing antibody - Independent containment of immunodeficiency virus challenges by DNA priming and recombinant pox virus booster immunizations
59. Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1 even in patients on effective combination therapy
60. Immune responses but no protection against SHIV by gene gun delivery of HIV-DNA followed by recombinant subunit protein boosts
61. HIV-1 env DNA vaccine administered to rhesus monkeys elicits MHC class II restricted CD4 T helper cells that secrete IFN-γ and IFN-α
62. Gene inoculation generates immune responses against human immunodeficiency virus type I
63. Potent protective anti-HIV immune responses generated by bimodal HIV envelop DNA plus protein vaccination
64. Increased immune response elicited by DNA vaccination with a synthetic gp 120 sequence with optimized codon usage
65. Safety and immunogenicity of HIV-1 DNA constructs in chimpazees
66. Modulation of amplitude and direction of in vivo immune responses by co-administration of cytokine gene expression cassettes with DNA immunogens
67. Cationic liposomes are a strong adjuvant of DNA vaccine for a human immunodeficiency virus type-1 (HIV-1)
68. Comparison of intranasal and intramuscular immunization against human immunodeficiency virus type-1
69. HIV specific cytotoxic T cell activity in an HIV exposed but uninfected infant
70. Late escape from an immunodominant cytotoxic T lymphocyte responses associated with progression to AIDS
71. Protection against a lethal influenza virus challenge by immunization with a haemagglutinin - Expressing plasmid DNA
72. Heterologous protection against influenza by injection of DNA encoding a viral protein
73. Genetic immunization against herpes simplex virus. Protection is mediated by CD4+ T lymphocytes
74. Bovine herpes virus-1: Immune responses in mice and cattle injected with plasmid DNA
75. Immunization with DNA
76. Nucleic acid vaccine encoding gD2 protects mice from herpes simplex virus type 2 disease
77. DNA immunization against experimental genital herpes simplex virus infections
78. Protection against leishmaniasis by injection of DNA encoding a major surface glycoproteins, gp63 of L. major
79. Protection against malaria by immunization with a Plasmodium yoelii circumsporozoite protein nucleic acid vaccine
80. Protection against mycoplasma infection using expression library immunization
81. Genes that induce immunity - DNA vaccines
82. Vaccination with plasmid vector carrying the rabies virus glycoprotein gene induces protective immunity against rabies vicus
83. DNA immunization protects non human primates against rabies virus
84. Induction of antigen specific cytotoxic T lymphocytes in humans by a malaria DNA vaccines
85. Immunization of female genital tract with DNA based vaccine
86. Simian immunodeficiency virus DNA vaccine trial in macaques
87. Potentiation of antigen specific Th1 immune responses by multiple DNA vaccination with an ovalbumin/interferon-γ hybrid construct
88. Utilization of MHC Class I transgenic mice for development of minigene DNA vaccines encoding multiple HLA restricted CTL epitopes
89. Deoxyribonucleic acid vaccines encoding antigens with rapid proteasome dependent degradation are highly efficient inducers of cytolytic T lymphocytes
90. Distribution of DNA vaccine determines their immunogenicity after intramuscular injection in mice
91. Contribution of cells at the site of DNA vaccination to the generation of antigen specification immunity and memory
92. Immunogenicity and protective efficacy of a tuberculous DNA vaccine
93. The genes coding for the antigen 85 complex of Mycobacterium tuberculosis and M. bovis BCG are members of a gene family: Cloning sequence determination and genomic organization of the gene for Ag-85C of M. tuberculosis
94. Cloning, sequence determination and expression of a 32kDa protein gene of Mycobacterium tuberculosis
95. Functions and specificity of T cells following nucleic acid vaccination of mice against Mycobacterium tuberculosis infection
96. Three different putative phosphate transport receptors are encoded by the Mycobacterium tuberculosis genome and are present at the surface of M. bovis BCG
97. Protection of chimpanzees from high dose heterologous HIV-1 challenge by DNA vaccination